Mizuho Medy Co Ltd
TSE:4595
Mizuho Medy Co Ltd
Interest Income Expense
Mizuho Medy Co Ltd
Interest Income Expense Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Mizuho Medy Co Ltd
TSE:4595
|
Interest Income Expense
¥242m
|
CAGR 3-Years
558%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Terumo Corp
TSE:4543
|
Interest Income Expense
-¥1.2B
|
CAGR 3-Years
22%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Olympus Corp
TSE:7733
|
Interest Income Expense
-¥5.1B
|
CAGR 3-Years
8%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
4%
|
|
|
Sysmex Corp
TSE:6869
|
Interest Income Expense
-¥6.2B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Nihon Kohden Corp
TSE:6849
|
Interest Income Expense
¥5.5B
|
CAGR 3-Years
23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
16%
|
|
|
JEOL Ltd
TSE:6951
|
Interest Income Expense
¥410m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
1%
|
|
Mizuho Medy Co Ltd
Glance View
Mizuho Medy Co., Ltd. engages in the research, development, manufacture and distribution of in-vitro diagnostic products. The company is headquartered in Tosu-Shi, Saga-Ken and currently employs 173 full-time employees. The company went IPO on 2015-12-17. The firm mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.
See Also
What is Mizuho Medy Co Ltd's Interest Income Expense?
Interest Income Expense
242m
JPY
Based on the financial report for Dec 31, 2024, Mizuho Medy Co Ltd's Interest Income Expense amounts to 242m JPY.
What is Mizuho Medy Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 3Y
558%
Over the last year, the Interest Income Expense growth was 82%. The average annual Interest Income Expense growth rates for Mizuho Medy Co Ltd have been 558% over the past three years .
You don't have any saved screeners yet